Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-13-000739

EXEC VP, CFO AND CBO sold 40,000 shares at $11.06 ($442,400)

  • EXEC VP, CFO AND CBO acquired 34,029 shares (option exercise)
  • EXEC VP, CFO AND CBO gave 40,000 shares (gift)
  • EXEC VP, CFO AND CBO gave 40,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise +7,500 $1.08 $8,100 57,971 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise +12,500 $2.00 $25,000 70,471 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise +14,029 $1.55 $21,745 84,500 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Gift −40,000 44,500 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Gift +40,000 40,000 I
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Sale −40,000 $11.06 $442,400 0 I
Derivatives
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise · Stock Option (right to buy) −7,500 0 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise · Stock Option (right to buy) −12,500 0 D
Aasen Thomas H EXEC VP, CFO AND CBO 2013-04-11 Option exercise · Stock Option (right to buy) −14,029 73,708 D
Open-market sales · 40,000 sh · avg $11.06 · $442,400
Loading xslF345X03/form4-04122013_110425.xml…